Copyright
©The Author(s) 2023.
World J Clin Cases. Aug 6, 2023; 11(22): 5252-5272
Published online Aug 6, 2023. doi: 10.12998/wjcc.v11.i22.5252
Published online Aug 6, 2023. doi: 10.12998/wjcc.v11.i22.5252
Treatment | Comments |
Infection control measures | To prevent the spread of COVID-19, following the public health guidelines, such as social distancing, wearing a face mask, and practicing good hand hygiene |
Treatment of COVID-19 | Treatment of COVID-19 should be made on a case-by-case basis, based on the severity of COVID-19 and the patient's overall health status |
Antiviral therapy such as Remdesivir and Molnupiravir, could be used in patients with COVID-19 to reduce the severity and duration of the illness. However, there is limited evidence for the effectiveness of antiviral therapy for COVID-19-induced gastrointestinal autonomic dysfunction | |
Immunomodulatory therapy in severe cases of COVID-19-induced gastrointestinal autonomic dysfunction, such as corticosteroids or monoclonal antibodies such as Tocilizumab, may be needed to reduce inflammation and prevent complications | |
Oxygen therapy may be needed | |
Manage any other COVID-19-related complications that may arise | |
Supportive management | ORT, intravenous fluids, and electrolyte replacement therapy |
Getting enough rest is crucial to enhance recovery | |
Symptomatic treatment | Management for abdominal pain with antispasmodics and analgesics such as acetaminophen or nonsteroidal anti-inflammatory drugs. Avoid using anticholinergics or opioids, as they can exacerbate gastrointestinal autonomic dysfunction |
For nausea and vomiting: Antiemetic and prokinetics such as ondansetron or metoclopramide | |
For diarrhoea: Antidiarrheals such as loperamide or bismuth subsalicylate | |
Constipation: Laxatives | |
Caution should be taken as symptomatic treatment may mask underlying symptoms of COVID-19 | |
Managing autonomic dysfunction | Using medications such as alpha-adrenergic agonists, beta-blockers, or anticholinergic medications to regulate the autonomic nervous system, depending on the specific symptoms and severity of autonomic dysfunction. However, these medications must be used cautiously, as they can induce side effects and interact with other medications. Specific treatment for orthostatic hypotension, tachycardia, and syncope should be according to the guidelines |
Treatment of complications | Treatment of dehydration and electrolyte imbalances, especially in children and the elderly |
Treatment of gastroparesis: Prokinetic agents, such as erythromycin or metoclopramide, may be needed to promote gastric emptying, improve gastrointestinal motility, relieve gastroparesis symptoms, and relieve symptoms of constipation | |
Treatment of malnutrition | |
Treatment of bowel obstruction or perforation: Surgical management | |
Treatment of bacterial superinfections and/or sepsis | |
Severe disease may may require ICU admission, mechanical ventilation, or ECMO support | |
Treating underlying conditions | IBD: Anti-inflammatory drugs, immunosuppressants such as corticosteroids, immunomodulators, biologic therapies, and antibiotics with adjustments to their regular treatment regimen or referral to a specialist. Diet modifications by avoiding trigger foods that exacerbate symptoms may help manage IBD symptoms. A low FODMAP diet may be beneficial for some people with IBD. Stress management and regular exercise could help. Surgery may be indicated in severe cases |
IBS: Diet modifications medications such as antispasmodics, laxatives, and antidepressants to help alleviate symptoms, probiotics, stress management, and regular exercise | |
Malignancy therapy should be personalized according to the type of malignancy by surgery, chemotherapy, radiotherapy, palliative therapy, immunomodulators, and supportive care | |
Nutritional support | Maintain adequate caloric intake, prevent malnutrition, follow a bland diet, and avoid spicy, fatty, or acidic foods that may worsen symptoms |
Nutritional support may be necessary for patients with decreased appetite or weight loss | |
Nutritional supplements or enteral or parenteral nutrition according to the situation | |
Probiotics positively affect the gut microbiota, improving gut dysbiosis that is common in gastrointestinal disorders and helping improve gastrointestinal symptoms such as bloating, constipation, and diarrhea. Prebiotics promote the growth of beneficial gut bacteria, which can improve gut health and potentially alleviate the associated symptoms. The optimal dosage, duration, and strains of probiotics/prebiotics could differ depending on the patient’s characteristics and the underlying pathophysiology of gastrointestinal autonomic dysfunction | |
Psychological support | Treatment of psychological distress induced by the symptoms of gastrointestinal autonomic dysfunction |
Psychological support, such as counseling or psychotherapy | |
Follow-up and Rehabilitation care | Regular check-ups with a healthcare professional may be necessary depending on the severity of the condition |
Aiming to monitor the resolution of symptoms, prevent long-term complications, and improve the patient's quality of life and functional status | |
Rehabilitation may include occupational therapy, physical therapy, speech therapy, and psychological support to manage potential complications and improve the overall quality of life | |
Physical therapy can help manage autonomic dysfunction symptoms, including gastrointestinal symptoms. Physical activities such as postural changes and deep breathing exercises can facilitate improved blood flow and reduce the symptoms |
- Citation: Elbeltagi R, Al-Beltagi M, Saeed NK, Bediwy AS. COVID-19-induced gastrointestinal autonomic dysfunction: A systematic review. World J Clin Cases 2023; 11(22): 5252-5272
- URL: https://www.wjgnet.com/2307-8960/full/v11/i22/5252.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i22.5252